Update on the Belgian Cancer Registry,



Similar documents
Cancer in Ireland 2013: Annual report of the National Cancer Registry

Prostate cancer statistics

Singapore Cancer Registry Annual Registry Report Trends in Cancer Incidence in Singapore National Registry of Diseases Office (NRDO)

Statistics fact sheet

Gen Re Dread Disease Survey Initial Results


Number. Source: Vital Records, M CDPH

Cancer research in the Midland Region the prostate and bowel cancer projects

Section 8» Incidence, Mortality, Survival and Prevalence

No. prev. doc.: 8770/08 SAN 64 Subject: EMPLOYMENT, SOCIAL POLICY, HEALTH AND CONSUMER AFFAIRS COUNCIL MEETING ON 9 AND 10 JUNE 2008

The Ontario Cancer Registry moves to the 21 st Century

Prevent what is preventable, cure what is curable, provide palliative care for patients in need, and monitor and manage for results.

Cancer in Wales. People living longer increases the number of new cancer cases

New Zealand mortality statistics: 1950 to 2010

Cancer incidence and mortality in Europe, 2004

Cancer Survival in Belgium

Chapter 2: Health in Wales and the United Kingdom

UICC World Cancer Congress. Cancer Staging and Quality of Care

Cancer Screening and Early Detection Guidelines

The Belgian Asbestos Fund

The Burden of Cancer in Asia

Making trees from paper. Towards transparent care and decision making by guideline based information standards and decision support

LifeProtect. Cancer Cover. For Intermediary Use Only

Non-Hodgkin Lymphoma in Queensland An Overview 2012

Final Report Australian Firefighters Health Study. Summary

The effect of the introduction of ICD-10 on cancer mortality trends in England and Wales

Index. Registry Report

Butler Memorial Hospital Community Health Needs Assessment 2013

Cost of Cancer in NSW A report by Access Economics Pty Limited for The Cancer Council NSW

Radiotherapy in Hungary: present status and future needs. Tibor Major, PhD National Institute of Oncology Radiotherapy Department Budapest, Hungary

Investigating Community Cancer Concerns--Deer Park Community Advisory Council, 2008

Cancer in Cumbria Jennifer Clay Public Health Intelligence Analyst November

Temporal Trends in Demographics and Overall Survival of Non Small-Cell Lung Cancer Patients at Moffitt Cancer Center From 1986 to 2008

The Health and Well-being of the Aboriginal Population in British Columbia

THE AUSTRALIAN MESOTHELIOMA REGISTRY (AMR)

Cancer in Primary Care: Prostate Cancer Screening. How and How often? Should we and in which patients?

How To Know If You Have Cancer At Mercy Regional Medical Center

"Belgian Universal Design Education Project ( )" Universal Design Design for All

Measures of Prognosis. Sukon Kanchanaraksa, PhD Johns Hopkins University

Market Update

Key Health Areas Mapped to Out of Hospital Programme Areas

Terminal illness pricing considerations. Steve Varney

ST JOSEPH REGIONAL HEALTH CENTER LUNG CANCER ANALYSIS Incidence, Diagnosis, Treatment and Survival

SECOND PRIMARY BREAST CANCERS FOLLOWING HAEMATOLOGIC MALIGNANCIES A CASE SERIES STUDY FARAH TANVEER PGY 3 DR.MEIR WETZLER DR.

Decision to Continue the Development of Tecemotide (L-BLP25) in Non-Small Cell Lung Cancer to be Announced

Critical Illness Products in South Africa

Patient Access to Cancer Drugs in Nine Countries in the Middle East

Table 2.2. Cohort studies of consumption of alcoholic beverages and cancer in special populations

Big Data and Oncology Care Quality Improvement in the United States

CONTINUING MEDICAL EDUCATION

Early mortality rate (EMR) in Acute Myeloid Leukemia (AML)

Chapter I Overview Chapter Contents

Rare Thoracic Tumours

Cancer patients waiting for potentially live-saving treatments in UK

C a nc e r C e nter. Annual Registry Report

Cancer Incidence and Survival By Major Ethnic Group, England,

Social inequalities impacts of care management and survival in patients with non-hodgkin lymphomas (ISO-LYMPH)

KINGS COUNTY HOSPITAL CENTER EXECUTIVE SUMMARY. Always Here When You Need Us

Six Degrees of Separation No More: Using Data Linkages to Improve the Quality of Cancer Registry and Study Data

Mužík J., Dušek L., Blaha M., Klika P. Institute of Biostatistics and Analyses, Masaryk University, Brno, Czech republic

INTERNSHIP Tourist Office for Flanders Brussels New York City

THINGS TO BE AWARE OF ABOUT PROSTATE AND LUNG CANCER. Lawrence Lackey Jr., M.D. Internal Medicine 6001 W. Outer Dr. Ste 114

CHRONIC DISEASE HEALTH PROFILE REGIONS AND COUNTIES: TENNESSEE EAST REGION

Survivorship Care Plans Guides for Living After Cancer Treatment

Epidemiology, Staging and Treatment of Lung Cancer. Mark A. Socinski, MD

European Parliament resolution on breast cancer in the European Union (2002/2279(INI))

Selected Health Status Indicators DALLAS COUNTY. Jointly produced to assist those seeking to improve health care in rural Alabama

Transcription:

Update on the Belgian Cancer Registry, breast cancer data... Belgian Breast Meeting 3-4/10/2008 Liesbet Van Eycken

Overview Introduction, history of the BCR Breast Cancer Incidence - Mortality Europe Belgium Flanders

History cancer registration in Belgium 1955 Obligatory health insurance social disease 1983 NKR-RNC 1994 AKR/LIKAR 2002 CIV IACR Flemish Network 1950 1960 1970 1980 1990 2000 2003 KB MOC - KB normen onco basiszorg en progr 2005: -STOP NCR

Belgian Cancer Registry Founded 1/7/2005 Collaboration between physicians, autorities and health insurances 12/2006: Health Law, art. 39: Kankerregister- Registre du Cancer Autorisation to use the national number Description of data transfer and pathways Clinical pathway (moc non moc) Pathology and Hematology pathway Cancer Plan March 2008 All cancers MOC Data manager funding in the hospital...

Actual Data sources Belgian Cancer Registry Hospitals: Oncol Care MOC non-moc Pathology labs Haematology Health Insurances Belgian Cancer Registry

CANCER IN EUROPE, 2006 3.191.600 new cancer cases 53% males 47% females 1.703.000 cancer deaths 56% males 44% females Ferlay J et al, Ann Onc 2007, doi:10.1093/annonc/mdl498

Cancer incidence and mortality, estimates 2006 EUROPE Incidence (n) Total: 3.191.600 Mortality (n) Total: 1.703.000 Breast: 429.900 Colorectal: 412.900 Lung: 386.300 Prostate: 346.000 Lung: 334.800 Colorectal: 207.000 Breast: 131.900 Stomach: 118.200 Ferlay J et al, Ann Onc 2007, doi:10.1093/annonc/mdl498

2004, Breast Cancer, Belgium: 9.406 new cases Borstkanker in België, 2004 Absolute aantallen 1400 Aantallen / 100.000 500,0 1200 1000 450,0 400,0 350,0 800 300,0 250,0 600 200,0 400 200 150,0 100,0 50,0 0 00-05- 10-15- 20-25- 30-35- 40-45- 50-55- 60-65- 70-75- 80-85+ Leeftijdscategorie 0,0 Absolute aantallen Aantallen / 100.000

Breast Cancer, 2004 Belgium 9.406 Flemish Region 5.374 Walloon region 3.101 Brussels region 931 57% 33% 10%

Breast Cancer, Age standardised incidence, 2004 breast Wallonië Brussel Vlaanderen 0 20 40 60 80 100 120 140 160 180 ESR (n/100,000)

n/100,000 Breast cancer, 2004, Age specific incidence 700,0 600,0 500,0 400,0 300,0 Flemish Region Walloon Region Brussels Region 200,0 100,0 0,0 00-05- 10-15- 20-25- 30-35- 40-45- 50-55- 60-65- 70-75- 80-85+ age

Reasons? Methodology? Check (Wall-Bxl) Administrative procedures? Prevalent cases? Result check: >3.000 cases: change of 2,2%! Influence screening programs (timing)? Risk factors? Next years?...

ESR (Aantallen / 100.000) Breast Cancer: evolution of age stand. incidence rates Flemish Region Flanders: evolution of age standardised incidence rates (3 age categories) 450 400 350 300 250 200 150 100 50 0 1997 1998 1999 2000 2001 2002 2003 2004 2005 Jaar 0-49 50-69 70+ alle leeftijden

Flemish Region, Breast Cancer: evolution of incidence and mortality per age category <50 y 50-69y 70+ ESR (N/100.000) Borstkanker in Vlaanderen, Leeftijdscategorie 0-49 Mortaliteit versus incidentie ESR (N/100.000) Borstkanker in Vlaanderen, Leeftijdscategorie 50-69 Mortaliteit versus incidentie ESR (N/100.000) Borstkanker in Vlaanderen, Leeftijdscategorie 70+ Mortaliteit versus incidentie 450 450 450 400 400 400 350 350 350 300 300 300 250 250 250 200 200 200 150 150 150 100 100 100 50 50 50 0 2000 2001 2002 2003 2004 Jaar Incidentie Mortaliteit 0 2000 2001 2002 2003 2004 Jaar Incidentie Mortaliteit 0 2000 2001 2002 2003 2004 Jaar Incidentie Mortaliteit

gestandaardiseerd cijfer (1/100.000 inw.) Breast cancer mortality, Flemish Region, 1994-2004 40-69 years: breast cancer is the most important cause of death Direct Gestandaardiseerde sterfte door borstkanker. Vlaams Gewest. Betrouwbaarheidsintervallen BG 50 48 ASR OG 46 Linear (ASR) 44 42 40 38 y = -0,7776x + 47,125 R 2 = 0,7776 36 34 32 30 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004

Flemish Region, breast cancer: 5y relative survival per stage Borstkanker in Vlaanderen: Relatieve overleving per stadium, 1997-2001 100% 90% 80% 70% 60% 50% 40% 30% 20% 10% 0% 0 12 24 36 48 60 Maand I II III IV X

ESR (Aantallen / 100.000) Breast Cancer, all ages, flemish region: stage distribution Breast Cancer, all ages: stage distribution, 1997-2005 100% 90% 80% 70% 60% 50% 40% 30% 20% 10% 0% 1997 1998 1999 2000 2001 2002 2003 2004 2005 Jaar IV III II I

ESR (Aantallen / 100.000) Breast Cancer, 50-69 years, flemish region: stage distribution Breast cancer, 50-69 years: stage distribution, 1997-2005 100% 90% 80% 70% 60% 50% 40% 30% 20% 10% 0% 1997 1998 1999 2000 2001 2002 2003 2004 2005 Jaar IV III II I

Europe: 5-year relative survival, 1995-1999 Eurocare-4 F. Berrino et al. 2007

Europe, breast cancer: 5-year relative survival, 1995-1999 Eurocare-4 F. Berrino et al. 2007

5 year relative survival, all cancers, 1995-1999 TNEH

Conclusion Breast Cancer High incidence in Belgium Differences in incidence in the Belgian regions Further investigations! TNM evolution? Mortality decreasing over time Survival data comparable with the European results Up to a cancer registry for Belgium with useful data for health care workers, autorities, research, etc...

Thank you! And... Thank you Cancer Registry team!